{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:51:28Z","timestamp":1791874288775,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T00:00:00Z","timestamp":1387411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T00:00:00Z","timestamp":1387411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms3907","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T11:04:10Z","timestamp":1387451050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Indoleamides are active against drug-resistant Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"4","author":[{"given":"Shichun","family":"Lun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluseye K.","family":"Onajole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendra","family":"Gunosewoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Tipparaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Ammerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Kozikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,19]]},"reference":[{"key":"BFncomms3907_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 2012 (2012)."},{"key":"BFncomms3907_CR2","unstructured":"United States Food and Drug Administration. Sirturo (bedaquiline) NDA 204384 Accelerated Approval Letter. 28 December 2012. (2012)."},{"key":"BFncomms3907_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","volume":"307","author":"K Andries","year":"2005","unstructured":"Andries, K. et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307, 223\u2013227 (2005).","journal-title":"Science"},{"key":"BFncomms3907_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.tube.2009.05.008","volume":"89","author":"S Ananthan","year":"2009","unstructured":"Ananthan, S. et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) 89, 334\u2013353 (2009).","journal-title":"Tuberculosis (Edinb)"},{"key":"BFncomms3907_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/156802612799984544","volume":"12","author":"A Lilienkampf","year":"2012","unstructured":"Lilienkampf, A., Pieroni, M., Franzblau, S. G., Bishai, W. R. & Kozikowski, A. P. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis. Curr. Top. Med. Chem. 12, 729\u2013734 (2012).","journal-title":"Curr. Top. Med. Chem."},{"key":"BFncomms3907_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cmdc.200700112","volume":"2","author":"J Mao","year":"2007","unstructured":"Mao, J., Wang, Y., Wan, B., Kozikowski, A. P. & Franzblau, S. G. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents. Chem. Med. Chem. 2, 1624\u20131630 (2007).","journal-title":"Chem. Med. Chem."},{"key":"BFncomms3907_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cmdc.201000490","volume":"6","author":"M Pieroni","year":"2011","unstructured":"Pieroni, M. et al. Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB. Chem. Med. Chem. 6, 334\u2013342 (2011).","journal-title":"Chem. Med. Chem."},{"key":"BFncomms3907_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","volume":"41","author":"L Collins","year":"1997","unstructured":"Collins, L. & Franzblau, S. G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41, 1004\u20131009 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms3907_CR9","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1021\/jm4003878","volume":"56","author":"OK Onajole","year":"2013","unstructured":"Onajole, O. K. et al. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. J. Med. Chem. 56, 4093\u20134103 (2013).","journal-title":"J. Med. Chem."},{"key":"BFncomms3907_CR10","doi-asserted-by":"publisher","first-page":"e7778","DOI":"10.1371\/journal.pone.0007778","volume":"4","author":"TR Ioerger","year":"2009","unstructured":"Ioerger, T. R. et al. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 4, e7778 (2009).","journal-title":"PLoS One"},{"key":"BFncomms3907_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29\u201340 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms3907_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nchembio.794","volume":"8","author":"AE Grzegorzewicz","year":"2012","unstructured":"Grzegorzewicz, A. E. et al. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat. Chem. Biol. 8, 334\u2013341 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"BFncomms3907_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/AAC.05270-11","volume":"56","author":"V La Rosa","year":"2012","unstructured":"La Rosa, V. et al. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob. Agents Chemother. 56, 324\u2013331 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms3907_CR14","doi-asserted-by":"publisher","first-page":"e56980","DOI":"10.1371\/journal.pone.0056980","volume":"8","author":"G Poce","year":"2013","unstructured":"Poce, G. et al. Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection. PLoS One 8, e56980 (2013).","journal-title":"PLoS One"},{"key":"BFncomms3907_CR15","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.05708-11","volume":"56","author":"K Tahlan","year":"2012","unstructured":"Tahlan, K. et al. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56, 1797\u20131809 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms3907_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cmdc.201200428","volume":"8","author":"L Ballell","year":"2013","unstructured":"Ballell, L. et al. Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. Chem. Med. Chem. 8, 313\u2013321 (2013).","journal-title":"Chem. Med. Chem."},{"key":"BFncomms3907_CR17","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1128\/IAI.73.6.3492-3501.2005","volume":"73","author":"P Domenech","year":"2005","unstructured":"Domenech, P., Reed, M. B. & Barry, C. E. 3rd Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73, 3492\u20133501 (2005).","journal-title":"Infect. Immun."},{"key":"BFncomms3907_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"LJ Piddock","year":"2006","unstructured":"Piddock, L. J. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4, 629\u2013636 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms3907_CR19","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1073\/pnas.1009516108","volume":"108","author":"MV Tullius","year":"2011","unstructured":"Tullius, M. V. et al. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc. Natl Acad. Sci. USA 108, 5051\u20135056 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms3907_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.chembiol.2012.03.006","volume":"19","author":"C Varela","year":"2012","unstructured":"Varela, C. et al. MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria. Chem. Biol. 19, 498\u2013506 (2012).","journal-title":"Chem. Biol."},{"key":"BFncomms3907_CR21","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.bmc.2013.02.028","volume":"21","author":"EJ North","year":"2013","unstructured":"North, E. J. et al. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties. Bioorg. Med. Chem. 21, 2587\u20132599 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"BFncomms3907_CR22","doi-asserted-by":"publisher","first-page":"e60933","DOI":"10.1371\/journal.pone.0060933","volume":"8","author":"MJ Remui\u00f1\u00e1n","year":"2013","unstructured":"Remui\u00f1\u00e1n, M. J. et al. Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6\u2032,7\u2032-dihydrospiro[piperidine-4,4\u2032-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3. PLoS One 8, e60933 (2013).","journal-title":"PLoS One"},{"key":"BFncomms3907_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.micro.61.111606.122346","volume":"61","author":"C Vilcheze","year":"2007","unstructured":"Vilcheze, C. & Jacobs, W. R. Jr The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61, 35\u201350 (2007).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFncomms3907_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2217\/fmb.12.56","volume":"7","author":"KA Sacksteder","year":"2012","unstructured":"Sacksteder, K. A., Protopopova, M., Barry, C. E. 3rd, Andries, K. & Nacy, C. A. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action. Future Microbiol. 7, 823\u2013837 (2012).","journal-title":"Future Microbiol."},{"key":"BFncomms3907_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.bjp.0705984","volume":"144","author":"L Jia","year":"2005","unstructured":"Jia, L. et al. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. Br. J. Pharmacol. 144, 80\u201387 (2005).","journal-title":"Br. J. Pharmacol."},{"key":"BFncomms3907_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","volume":"393","author":"ST Cole","year":"1998","unstructured":"Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537\u2013544 (1998).","journal-title":"Nature"},{"key":"BFncomms3907_CR27","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms3907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms3907","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms3907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T01:14:07Z","timestamp":1672967647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms3907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFncomms3907"],"URL":"https:\/\/doi.org\/10.1038\/ncomms3907","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,19]]},"assertion":[{"value":"2 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2907"}}